FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3040432015> ?p ?o ?g. }

• W3040432015 endingPage "206" @default.
• W3040432015 startingPage "196" @default.
• W3040432015 abstract "Abstract Objectives To evaluate the feasibility and preliminary effectiveness of iCanCope with Pain (iCanCope), a smartphone-based pain self-management program, in adolescents with JIA. iCanCope featured symptom tracking, goal-setting, pain coping skills and social support. Methods A two-arm pilot randomized controlled trial was used to evaluate the iCanCope app compared with a version with symptom tracking only. Primary (feasibility) outcomes were: participant accrual/attrition rates, success of app deployment, acceptability and adherence. Secondary (preliminary effectiveness) outcomes were: pain intensity, pain-related activity limitations and health-related quality of life. Outcomes were assessed at baseline and 8 weeks. Adherence was defined as the proportion of completed symptom reports: ‘low’ (≤24%); ‘low-moderate’ (25–49%); ‘high-moderate’ (50–75%); or ‘high’ (76–100%). Linear mixed models were applied for preliminary effectiveness analyses as per intention-to-treat. Results Adolescents (N = 60) were recruited from three paediatric rheumatology centres. Rates of accrual and attrition were 82 and 13%, respectively. Both apps were deployed with high success (over 85%) and were rated as highly acceptable. Adherence was similar for both groups, with most participants demonstrating moderate-to-high adherence. Both groups exhibited a clinically meaningful reduction in pain intensity (≥1 point) that did not statistically differ between groups. There were no significant changes in activity limitations or health-related quality of life. Conclusion The iCanCope pilot randomized controlled trial was feasible to implement in a paediatric rheumatology setting. Both apps were deployed successfully, with high acceptability, and were associated with moderate-to-high adherence. Preliminary reductions in pain intensity warrant a future trial to evaluate effectiveness of iCanCope in improving health outcomes in adolescents with JIA. Trial registration ClinicalTrials.gov identifier: NCT02764346." @default.
• W3040432015 created "2020-07-10" @default.
• W3040432015 creator A5003466194 @default.
• W3040432015 creator A5007941133 @default.
• W3040432015 creator A5015352382 @default.
• W3040432015 creator A5024132730 @default.
• W3040432015 creator A5030955894 @default.
• W3040432015 creator A5032187087 @default.
• W3040432015 creator A5034276770 @default.
• W3040432015 creator A5042979209 @default.
• W3040432015 creator A5043518902 @default.
• W3040432015 creator A5056956491 @default.
• W3040432015 creator A5059108613 @default.
• W3040432015 creator A5060660899 @default.
• W3040432015 creator A5061015297 @default.
• W3040432015 creator A5071159283 @default.
• W3040432015 creator A5074414209 @default.
• W3040432015 creator A5078753446 @default.
• W3040432015 creator A5090384903 @default.
• W3040432015 date "2020-07-02" @default.
• W3040432015 modified "2023-10-15" @default.
• W3040432015 title "The <i>iCanCope</i> pain self-management application for adolescents with juvenile idiopathic arthritis: a pilot randomized controlled trial" @default.
• W3040432015 cites W1969088090 @default.
• W3040432015 cites W1972046137 @default.
• W3040432015 cites W1981327243 @default.
• W3040432015 cites W1985859049 @default.
• W3040432015 cites W1992167600 @default.
• W3040432015 cites W1995070454 @default.
• W3040432015 cites W2002851739 @default.
• W3040432015 cites W2003140096 @default.
• W3040432015 cites W2011911794 @default.
• W3040432015 cites W2025977472 @default.
• W3040432015 cites W2083379705 @default.
• W3040432015 cites W2103080374 @default.
• W3040432015 cites W2117034008 @default.
• W3040432015 cites W2121228031 @default.
• W3040432015 cites W2127769616 @default.
• W3040432015 cites W2129394198 @default.
• W3040432015 cites W2131171698 @default.
• W3040432015 cites W2148339719 @default.
• W3040432015 cites W2153482305 @default.
• W3040432015 cites W2507450497 @default.
• W3040432015 cites W2510814766 @default.
• W3040432015 cites W2614590235 @default.
• W3040432015 cites W2742889305 @default.
• W3040432015 cites W2743885058 @default.
• W3040432015 cites W2753369600 @default.
• W3040432015 cites W2786182520 @default.
• W3040432015 cites W2790236647 @default.
• W3040432015 cites W2889059924 @default.
• W3040432015 cites W2896085962 @default.
• W3040432015 cites W2910244894 @default.
• W3040432015 cites W2910568111 @default.
• W3040432015 cites W2913630416 @default.
• W3040432015 cites W2971794993 @default.
• W3040432015 cites W2987135437 @default.
• W3040432015 cites W2999372441 @default.
• W3040432015 cites W4236805817 @default.
• W3040432015 cites W88007950 @default.
• W3040432015 doi "https://doi.org/10.1093/rheumatology/keaa178" @default.
• W3040432015 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32613229" @default.
• W3040432015 hasPublicationYear "2020" @default.
• W3040432015 type Work @default.
• W3040432015 sameAs 3040432015 @default.
• W3040432015 citedByCount "24" @default.
• W3040432015 countsByYear W30404320152021 @default.
• W3040432015 countsByYear W30404320152022 @default.
• W3040432015 countsByYear W30404320152023 @default.
• W3040432015 crossrefType "journal-article" @default.
• W3040432015 hasAuthorship W3040432015A5003466194 @default.
• W3040432015 hasAuthorship W3040432015A5007941133 @default.
• W3040432015 hasAuthorship W3040432015A5015352382 @default.
• W3040432015 hasAuthorship W3040432015A5024132730 @default.
• W3040432015 hasAuthorship W3040432015A5030955894 @default.
• W3040432015 hasAuthorship W3040432015A5032187087 @default.
• W3040432015 hasAuthorship W3040432015A5034276770 @default.
• W3040432015 hasAuthorship W3040432015A5042979209 @default.
• W3040432015 hasAuthorship W3040432015A5043518902 @default.
• W3040432015 hasAuthorship W3040432015A5056956491 @default.
• W3040432015 hasAuthorship W3040432015A5059108613 @default.
• W3040432015 hasAuthorship W3040432015A5060660899 @default.
• W3040432015 hasAuthorship W3040432015A5061015297 @default.
• W3040432015 hasAuthorship W3040432015A5071159283 @default.
• W3040432015 hasAuthorship W3040432015A5074414209 @default.
• W3040432015 hasAuthorship W3040432015A5078753446 @default.
• W3040432015 hasAuthorship W3040432015A5090384903 @default.
• W3040432015 hasBestOaLocation W30404320151 @default.
• W3040432015 hasConcept C126322002 @default.
• W3040432015 hasConcept C159110408 @default.
• W3040432015 hasConcept C168563851 @default.
• W3040432015 hasConcept C1862650 @default.
• W3040432015 hasConcept C198451711 @default.
• W3040432015 hasConcept C199343813 @default.
• W3040432015 hasConcept C2779951463 @default.
• W3040432015 hasConcept C2780553607 @default.
• W3040432015 hasConcept C71924100 @default.
• W3040432015 hasConceptScore W3040432015C126322002 @default.
• W3040432015 hasConceptScore W3040432015C159110408 @default.

• next